US Stock MarketDetailed Quotes

Black Diamond Therapeutics (BDTX)

Watchlist
  • 2.650
  • +0.080+3.11%
Close Jan 22 16:00 ET
150.98MMarket Cap7.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Black Diamond Therapeutics (BDTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
70M
0
0
0
0
0
0
0
Operating revenue
--0
--0
--70M
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-39.45%10.98M
-39.36%13.42M
-23.59%15.47M
-8.88%78.78M
-12.37%18.28M
-24.50%18.13M
10.47%22.13M
-6.10%20.25M
-6.86%86.46M
-4.56%20.86M
Selling and administrative expenses
-32.11%3.54M
-57.17%4.1M
-25.92%4.96M
1.32%27.47M
7.40%5.98M
-33.62%5.22M
39.20%9.57M
-1.57%6.7M
-4.51%27.11M
-23.15%5.57M
-General and administrative expense
-32.11%3.54M
-57.17%4.1M
-25.92%4.96M
1.32%27.47M
7.40%5.98M
-33.62%5.22M
39.20%9.57M
-1.57%6.7M
-4.51%27.11M
-23.15%5.57M
Research and development costs
-42.41%7.44M
-25.78%9.32M
-22.44%10.51M
-13.54%51.31M
-19.57%12.3M
-20.06%12.91M
-4.55%12.56M
-8.19%13.55M
-7.89%59.35M
4.65%15.29M
Operating profit
39.45%-10.98M
39.36%-13.42M
369.34%54.53M
8.88%-78.78M
12.37%-18.28M
24.50%-18.13M
-10.47%-22.13M
6.10%-20.25M
6.86%-86.46M
4.56%-20.86M
Net non-operating interest income expense
125.58%1.16M
140.95%1.12M
-6.59%595K
13.41%2.18M
74.38%565K
17.54%516K
-13.91%464K
2.41%637K
-5.27%1.92M
-52.14%324K
Non-operating interest income
125.58%1.16M
140.95%1.12M
-6.59%595K
13.41%2.18M
74.38%565K
17.54%516K
-13.91%464K
2.41%637K
-5.27%1.92M
-52.14%324K
Other net income (expense)
-36.02%1.32M
-0.91%1.74M
2.38%1.42M
230.61%6.92M
53.61%1.73M
263.43%2.06M
415.25%1.76M
2,062.50%1.38M
662.90%2.09M
1,057.73%1.12M
Other non- operating income (expenses)
-36.02%1.32M
-0.91%1.74M
2.38%1.42M
230.61%6.92M
53.61%1.73M
263.43%2.06M
415.25%1.76M
2,062.50%1.38M
691.53%2.09M
876.52%1.12M
Income before tax
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
Income tax
Net income
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
Net income continuous Operations
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
Minority interest income
Net income attributable to the parent company
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
45.38%-8.5M
46.95%-10.56M
410.24%56.54M
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
Basic earnings per share
46.43%-0.15
47.22%-0.19
385.71%1
32.45%-1.27
17.65%-0.28
37.78%-0.28
30.77%-0.36
38.60%-0.35
25.40%-1.88
42.37%-0.34
Diluted earnings per share
46.43%-0.15
47.22%-0.19
380.00%0.98
32.45%-1.27
17.65%-0.28
37.78%-0.28
30.77%-0.36
38.60%-0.35
25.40%-1.88
42.37%-0.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0070M0000000
Operating revenue --0--0--70M--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -39.45%10.98M-39.36%13.42M-23.59%15.47M-8.88%78.78M-12.37%18.28M-24.50%18.13M10.47%22.13M-6.10%20.25M-6.86%86.46M-4.56%20.86M
Selling and administrative expenses -32.11%3.54M-57.17%4.1M-25.92%4.96M1.32%27.47M7.40%5.98M-33.62%5.22M39.20%9.57M-1.57%6.7M-4.51%27.11M-23.15%5.57M
-General and administrative expense -32.11%3.54M-57.17%4.1M-25.92%4.96M1.32%27.47M7.40%5.98M-33.62%5.22M39.20%9.57M-1.57%6.7M-4.51%27.11M-23.15%5.57M
Research and development costs -42.41%7.44M-25.78%9.32M-22.44%10.51M-13.54%51.31M-19.57%12.3M-20.06%12.91M-4.55%12.56M-8.19%13.55M-7.89%59.35M4.65%15.29M
Operating profit 39.45%-10.98M39.36%-13.42M369.34%54.53M8.88%-78.78M12.37%-18.28M24.50%-18.13M-10.47%-22.13M6.10%-20.25M6.86%-86.46M4.56%-20.86M
Net non-operating interest income expense 125.58%1.16M140.95%1.12M-6.59%595K13.41%2.18M74.38%565K17.54%516K-13.91%464K2.41%637K-5.27%1.92M-52.14%324K
Non-operating interest income 125.58%1.16M140.95%1.12M-6.59%595K13.41%2.18M74.38%565K17.54%516K-13.91%464K2.41%637K-5.27%1.92M-52.14%324K
Other net income (expense) -36.02%1.32M-0.91%1.74M2.38%1.42M230.61%6.92M53.61%1.73M263.43%2.06M415.25%1.76M2,062.50%1.38M662.90%2.09M1,057.73%1.12M
Other non- operating income (expenses) -36.02%1.32M-0.91%1.74M2.38%1.42M230.61%6.92M53.61%1.73M263.43%2.06M415.25%1.76M2,062.50%1.38M691.53%2.09M876.52%1.12M
Income before tax 45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M
Income tax
Net income 45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M
Net income continuous Operations 45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M
Minority interest income
Net income attributable to the parent company 45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 45.38%-8.5M46.95%-10.56M410.24%56.54M15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M
Basic earnings per share 46.43%-0.1547.22%-0.19385.71%132.45%-1.2717.65%-0.2837.78%-0.2830.77%-0.3638.60%-0.3525.40%-1.8842.37%-0.34
Diluted earnings per share 46.43%-0.1547.22%-0.19380.00%0.9832.45%-1.2717.65%-0.2837.78%-0.2830.77%-0.3638.60%-0.3525.40%-1.8842.37%-0.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -